These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1585676)

  • 1. [Therapeutic possibilities in systemic scleroderma].
    Sönnichsen N; Brenke A
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):227-30. PubMed ID: 1585676
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Systemic autoimmune diseases. 2) Systemic scleroderma and polymyositis].
    Kinoshita M; Yokohari R
    Nihon Rinsho; 1988 Apr; 46(4):873-8. PubMed ID: 3261361
    [No Abstract]   [Full Text] [Related]  

  • 3. [The clinical picture and therapy of progressive systemic scleroderma].
    Sönnichsen N; Brenke A; Witt C
    Dtsch Med Wochenschr; 1992 Mar; 117(11):427-31. PubMed ID: 1544345
    [No Abstract]   [Full Text] [Related]  

  • 4. [The local therapy of systemic scleroderma].
    Guseva NG
    Ter Arkh; 1990; 62(5):110-3. PubMed ID: 2396204
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of antinuclear autoantibodies in progressive systemic sclerosis and its clinical significance].
    Jiang M; Wang HZ; Yuan X
    Zhonghua Nei Ke Za Zhi; 1988 Feb; 27(2):112-4, 136. PubMed ID: 3053068
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Antismooth muscle antibody in scleroderma.
    Kitridou RC; Fleischmajer R; Lagosky PA
    Arthritis Rheum; 1975; 18(5):526. PubMed ID: 1081396
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis and treatment of scleroderma].
    Crickx B; Belaich S
    Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of generalized (progressive) scleroderma].
    Balda BR
    Dtsch Med Wochenschr; 1972 Dec; 97(48):1876-8. PubMed ID: 4117979
    [No Abstract]   [Full Text] [Related]  

  • 10. The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma).
    Senécal JL; Hénault J; Raymond Y
    J Rheumatol; 2005 Sep; 32(9):1643-9. PubMed ID: 16142854
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of anti-Scl-70 antibody and its clinical significance in progressive systemic sclerosis].
    Jiang M
    Zhonghua Yi Xue Za Zhi; 1986 Jun; 66(6):346-8, 384. PubMed ID: 3094898
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma].
    Murav'ev IuV; Aliab'eva AP; Sigidin IaA; Guseva NG; Balabanova RM
    Ter Arkh; 1985; 57(8):125-7. PubMed ID: 3906994
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antinuclear autoantibodies].
    Röther E; Peter HH
    Internist (Berl); 1995 Mar; 36(3):277-81. PubMed ID: 7737821
    [No Abstract]   [Full Text] [Related]  

  • 15. Scleroderma: therapeutic options.
    Connolly SM
    Cutis; 1984 Sep; 34(3):274-6. PubMed ID: 6386354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticentromere antibodies: clinical and biological significance.
    Fritzler MJ; Ayer LM
    J Rheumatol; 1982; 9(4):489-90. PubMed ID: 6982333
    [No Abstract]   [Full Text] [Related]  

  • 18. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients].
    Nebe H; Blume N
    Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of three methods for the detection of anti-SCL70 autoantibodies].
    Yalaoui S; Gorgi Y; Ayed K
    Ann Biol Clin (Paris); 2001; 59(5):639-42. PubMed ID: 11602398
    [No Abstract]   [Full Text] [Related]  

  • 20. [Generalized scleroderma associated at with active chronic hepatitis. Successive apparition of different serum antibodies].
    Husson JM; Petite JP; Homberg JC; Lunel J; Audebert A; Camilleri JP
    Nouv Presse Med; 1974 Dec; 3(45):2717-21. PubMed ID: 4549263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.